Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

González-Muñoz T, Di Giannatale A, García-Silva S, Santos V, Sánchez-Redondo S, Savini C, et al. Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis. Clin Cancer Res. 2023;29(18):3744-3758.

Saoud C, Illei PB, Siddiqui MT, Ali SZ. Cytopathology of rare gastric mesenchymal neoplasms: A series of 25 cases and review of literature. Cytopathology. 2023;34(1):15-27.

Setton J, Hadi K, Choo Z-, Kuchin KS, Tian H, Paula AD, et al. Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers. Nature. 2023;621(7977):129-137.

Ma C, Wang X, Dai JY, Turman C, Kraft P, Stopsack KH, et al. Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study. Cancer Epidemiol Biomarkers Prev. 2023;32(10):1436-1443.

Cheong J-, Ravishankar A, Sharma S, Parkhurst CN, Grassmann SA, Wingert CK, et al. Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell. 2023;186(18):3882-3902.e24.

Hoda SA, Hoda RS. "Time Shall Unfold…": The Clinical Value of Grading Mammary Angiosarcoma. Am J Surg Pathol. 2023;47(3):279-280.

Thomas JL, Tee MW, Harp J, Magro C. Azathioprine hypersensitivity syndrome manifesting as subcutaneous Sweet syndrome and acute pancreatitis. J Cutan Pathol. 2023;50(2):127-130.

Sigel C, Wei X-, Agaram N, Sigel K, Raza R, Andrade R, et al. Diagnostic features of low- and high-grade mucinous neoplasms in pancreatic cyst FNA cytology. Cancer Cytopathol. 2023;131(5):325-336.

Pallasaho S, Gondane A, Kuivalainen A, Girmay S, Moestue S, Loda M, et al. Castration-resistant prostate cancer cells are dependent on the high activity of CDK7. J Cancer Res Clin Oncol. 2023;149(8):5255-5263.

Zhang X, Zhao X, Fiskus W, Lin J, Lwin T, Rao R, et al. Retraction Notice to: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas. Cancer Cell. 2023;41(6):1198.